The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.


Updates from The Motley Fool

Latest updates on SIMULATIONS PLUS, INC. from Fool.com.

There is no available coverage of SIMULATIONS PLUS, INC. at this time.



Stock Performance

SLP vs. S&P 500 | 2 Year Performance
View Interactive SLP Charts
Sponsored by

Key Data Points

Primary metrics and data points about SIMULATIONS PLUS, INC..
Current Price: $8.19
Prev Close: $8.12
Open: $8.15
Bid: $7.95
Ask: $10.00
Day's Range: $8.03 - $8.23
52wk Range: $6.40 - $11.89
Volume: 5,177
Avg Vol 24,329
Market Cap: $139.20M
P/E (ttm): 30.07
EPS (ttm): $0.27
Div & Yield: $0.20 (2.5%)

Company Rating

What our community thinks about SIMULATIONS PLUS, INC..
CAPS Rating 4 out of 5
 
88 Outperform
5 Underperform
CAPS All Stars
 
15 Outperform
1 Underperform

How do you think SIMULATIONS PLUS, INC. will perform against the market?



You pick for SIMULATIONS PLUS, INC. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for SIMULATIONS PLUS, INC..

The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.

  • Exchange: NASDAQ
  • Sector: Technology
  • Industry: Computer Software & Services